FDA clears first “interchangeable” Humira biosimilarBiosimilar competition to AbbVie’s big-selling Humira drug in the US has just been ratcheted up by the FDA Share XFDA clears first “interchangeable” Humira biosimilarhttps://pharmaphorum.com/news/fda-clears-first-interchangeable-humira-biosimilar/
Use of digital tools for clinical trials triples during pandemic; surveyA new poll of clinical trial sponsors has found that around nine out of 10 of them are Share XUse of digital tools for clinical trials triples during pandemic; surveyhttps://pharmaphorum.com/news/use-of-digital-tools-for-clinical-trials-triples-during-pandemic-survey/
NICE changes stance on Sanofi’s Dupixent for severe asthma18 months after saying “no” to regular NHS funding for Sanofi and Regeneron’s Dupixent (dupilumab) for severe asthma Share XNICE changes stance on Sanofi’s Dupixent for severe asthmahttps://pharmaphorum.com/news/nice-changes-stance-on-sanofis-dupixent-for-severe-asthma/
Blow to Biogen as ALS hope tofersen flunks phase 3 trialAlready struggling to make headway with its recently launched Alzheimer’s drug, Biogen suffered a major late-stage pipeline setback Share XBlow to Biogen as ALS hope tofersen flunks phase 3 trialhttps://pharmaphorum.com/news/blow-to-biogen-as-als-hope-tofersen-flunks-phase-3-trial/
Roche scores adjuvant lung cancer approval for TecentriqRoche has claimed an earlier-than-expected FDA approval for its checkpoint inhibitor Tecentriq in non-small cell lung cancer (NSCLC), Share XRoche scores adjuvant lung cancer approval for Tecentriqhttps://pharmaphorum.com/news/roche-scores-early-adjuvant-lung-cancer-approval-for-tecentriq/
FDA panel backs booster shot for J&J COVID-19 vaccineAn FDA advisory committee voted unanimously in favour of a booster dose of Johnson & Johnson’s one-shot COVID-19 Share XFDA panel backs booster shot for J&J COVID-19 vaccinehttps://pharmaphorum.com/news/fda-panel-backs-booster-shot-for-jj-covid-19-vaccine/
UK hospital will use MindMaze game to aid stroke recoveryA hospital trust has become the first in the UK to deploy a gaming system developed by Swiss Share XUK hospital will use MindMaze game to aid stroke recoveryhttps://pharmaphorum.com/news/uk-hospital-will-use-mindmaze-game-to-aid-stroke-recovery/
Califf re-joining FDA would be positive for industry; analystWith rumours growing that that ex-FDA head Robert Califf looks set to receive President Joe Biden’s nomination to Share XCaliff re-joining FDA would be positive for industry; analysthttps://pharmaphorum.com/news/califf-re-joining-fda-would-be-positive-for-industry-analyst/
Actemra shortage spills over to include Sanofi’s rival KevzaraRoche’s Actemra has been in high demand since its value in treating severe COVID-19 was established, leading to Share XActemra shortage spills over to include Sanofi’s rival Kevzarahttps://pharmaphorum.com/news/actemra-shortage-spills-over-to-include-sanofis-rival-kevzara/
